Nicholas Uehlecke is named as a lobbyist on federal disclosure filings for 56 clients through Todd Strategy Group. The most recent filing naming them posted in October 2026. Issues reported include Health Issues, Medicare/Medicaid, Pharmacy and Trade (domestic/foreign).
Filers must list covered executive or legislative branch positions held. As filed:
| Client | Registrant | Latest | Issues |
|---|---|---|---|
| PERSONALIS, INC. | TODD STRATEGY GROUP | Q3 2026 | Medicare/Medicaid, Pharmacy |
| MRO CORPORATION | TODD STRATEGY GROUP | Q3 2026 | Health Issues |
| INOVIO PHARMACEUTICALS | TODD STRATEGY GROUP | Q3 2026 | Health Issues |
| HEALTHCARE PRIVACY FORUM, LLC D/B/A HEALTHCARE TRUST INSTITUTE | TODD STRATEGY GROUP | Q3 2026 | Health Issues |
| FREENOME | TODD STRATEGY GROUP | Q3 2026 | Medicare/Medicaid, Health Issues |
| GUARDANT HEALTH, INC. | TODD STRATEGY GROUP | Q2 2026 | Health Issues |
| U.S. CHAMBER OF COMMERCE GLOBAL INNOVATION POLICY CENTER | TODD STRATEGY GROUP | Q3 2026 | Copyright/Patent/Trademark |
| OTSUKA AMERICA PHARMACEUTICAL, INC. | TODD STRATEGY GROUP | Q3 2026 | Health Issues |
| ELI LILLY AND COMPANY | TODD STRATEGY GROUP | Q3 2026 | Medicare/Medicaid, Health Issues, Pharmacy |
| ASTELLAS PHARMA US, INC. | TODD STRATEGY GROUP | Q3 2026 | Copyright/Patent/Trademark, Pharmacy, Health Issues |
| AMERICAN MEDICAL ASSOCIATION | TODD STRATEGY GROUP | Q3 2026 | Medicare/Medicaid, Health Issues, Pharmacy |
| PUERTO RICO DEPARTMENT OF HEALTH | TODD STRATEGY GROUP | Q3 2026 | Medicare/Medicaid, Budget/Appropriations |
| MYRIAD GENETICS, INC. | TODD STRATEGY GROUP | Q3 2026 | Medicare/Medicaid |
| GLAXOSMITHKLINE LLC | TODD STRATEGY GROUP | Q3 2026 | Medicare/Medicaid, Health Issues |
| GENMAB | TODD STRATEGY GROUP | Q3 2026 | Medicare/Medicaid, Health Issues |
| FOX CORPORATION | TODD STRATEGY GROUP | Q3 2026 | Telecommunications, Communications/Broadcasting/Radio/TV, Taxation/Internal Revenue Code |
| CAREDX, INC. | TODD STRATEGY GROUP | Q2 2026 | Medicare/Medicaid |
| NOVO NORDISK INC. | TODD STRATEGY GROUP | Q3 2026 | Pharmacy, Health Issues |
| DELFI DIAGNOSTICS | TODD STRATEGY GROUP | Q3 2026 | Trade (domestic/foreign), Pharmacy, Health Issues |
| SOUTHWEST TRANSPLANT ALLIANCE | TODD STRATEGY GROUP | Q3 2026 | Health Issues |
| COMPASS PATHWAYS INC. | TODD STRATEGY GROUP | Q3 2026 | Health Issues |
| AMERICAN SOCIETY OF NEPHROLOGY | TODD STRATEGY GROUP | Q3 2026 | Health Issues |
| ALKERMES, INC. | TODD STRATEGY GROUP | Q3 2026 | Medicare/Medicaid, Health Issues |
| SUNBOUND HOMES | TODD STRATEGY GROUP | Q3 2026 | Medicare/Medicaid |
| PFIZER INC. | TODD STRATEGY GROUP | Q3 2026 | Trade (domestic/foreign), Medicare/Medicaid, Pharmacy |
| ILLUMINA, INC. | TODD STRATEGY GROUP | Q3 2026 | Trade (domestic/foreign), Medicare/Medicaid, Health Issues |
| BIOGEN, INC. | TODD STRATEGY GROUP | Q3 2026 | Medicare/Medicaid, Health Issues, Pharmacy |
| VANTIVE US HEALTHCARE LLC | TODD STRATEGY GROUP | Q3 2026 | Health Issues |
| TAKEDA PHARMACEUTICALS AMERICA, INC. | TODD STRATEGY GROUP | Q3 2026 | Trade (domestic/foreign), Medicare/Medicaid, Health Issues |
| SIDECAR HEALTH | TODD STRATEGY GROUP | Q3 2026 | Health Issues |
| NOVARTIS, INC. | TODD STRATEGY GROUP | Q3 2026 | Trade (domestic/foreign), Medicare/Medicaid, Health Issues |
| NCTA - THE INTERNET & TELEVISION ASSOCIATION | TODD STRATEGY GROUP | Q3 2026 | Telecommunications |
| MUTUAL OF OMAHA | TODD STRATEGY GROUP | Q3 2026 | Insurance |
| JOHNSON & JOHNSON SERVICES, INC. | TODD STRATEGY GROUP | Q3 2026 | Veterans, Health Issues |
| INSULET CORPORATION | TODD STRATEGY GROUP | Q3 2026 | Health Issues |
| CALYXO, INC. | TODD STRATEGY GROUP | Q3 2026 | Health Issues |
| BAYER CORPORATION | TODD STRATEGY GROUP | Q3 2026 | Trade (domestic/foreign), Taxation/Internal Revenue Code, Medicare/Medicaid |
| AMERICAN COLLEGE OF RADIOLOGY | TODD STRATEGY GROUP | Q3 2026 | Medicare/Medicaid |
| MERCK & CO., INC. | TODD STRATEGY GROUP | Q3 2026 | Medicare/Medicaid, Health Issues |
| APOLLO GLOBAL MANAGEMENT | TODD STRATEGY GROUP | Q3 2026 | Financial Institutions/Investments/Securities |
| SIEMENS HEALTHINEERS | TODD STRATEGY GROUP | Q1 2026 | Medicare/Medicaid |
| THE ORTHOFORUM | TODD STRATEGY GROUP | Q2 2026 | Medicare/Medicaid |
| KALEO | TODD STRATEGY GROUP | Q2 2026 | Pharmacy |
| KALDEROS, INC. | TODD STRATEGY GROUP | Q1 2026 | Health Issues |
| GENEOSCOPY, INC. | TODD STRATEGY GROUP | Q1 2026 | Health Issues |
| AMERICAN POLICY VENTURES ACTION | TODD STRATEGY GROUP | Q1 2026 | Economics/Economic Development, Taxation/Internal Revenue Code |
| VIAL HEALTH TECHNOLOGY, INC. | TODD STRATEGY GROUP | Q4 2025 | Health Issues |
| MED CLAIMS COMPLIANCE CORPORATION | TODD STRATEGY GROUP | Q4 2025 | Medicare/Medicaid |
| LYNCH REGENERATIVE MEDICINE, LLC | TODD STRATEGY GROUP | Q4 2025 | Medicare/Medicaid |
| ALLIANCE FOR AMERICA'S PROMISE, INC. | TODD STRATEGY GROUP | Q4 2025 | Veterans |
| NETLIST, INC. | TODD STRATEGY GROUP | Q4 2025 | Copyright/Patent/Trademark |
| OSRX PHARMACEUTICALS | TODD STRATEGY GROUP | Q2 2025 | Health Issues |
| HOSPICE COMPASSUS | TODD STRATEGY GROUP | Q2 2025 | Medicare/Medicaid, Health Issues |
| BRIDGEBIO PHARMA | TODD STRATEGY GROUP | Q2 2025 | Pharmacy |
| NOMI HEALTH, INC. | TODD STRATEGY GROUP | Q2 2025 | Health Issues |
| FLEXCARE | TODD STRATEGY GROUP | Q1 2025 | Health Issues |
| Year | Clients | Registrants |
|---|---|---|
| 2026 | 46 | 1 |
| 2025 | 49 | 1 |
| Year | Items | Total |
|---|---|---|
| 2026 | 15 | $39K |
Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name Nicholas Uehlecke. See the Capitol Clarity rankings and method.